OTCMKTS:OPNT
Delisted

Opiant Pharmaceuticals Stock News

etoro logo Buy OPNT
*Your capital is at risk
$20.65
+0 (+0%)
At Close: May 26, 2023
We used TipRanks analyst ranking service to pinpoint Wall Street's best-performing analysts.
Wellcome Trust slashed positions in Apple and Microsoft stock in the second quarter. It also initiated a position in Abbott Laboratories, and bought more Nike stock.

Guest lineups for the Sunday news shows

10:25pm, Saturday, 18'th Jul 2020
Guest lineups for the Sunday news shows
President Donald Trump has taken an increasingly hands-off approach to the coronavirus crisis in recent days even as COVID-19 cases and deaths have surged to record highs in a significant slice of the
Announcement of one before Election Day might help President Trump—or sow suspicions about the product
Bio-Thera Solutions Partners with Pharmapark to Market BAT2506 in Russia and other CIS Countries. BAT2506 is a proposed biosimilar of golimumab.
A federal dashboard that provides information to the public about COVID-19 data that is provided by hospitals has not been updated since a rapidly...
Wall Street brokerages expect Opiant Pharmaceuticals Inc (NASDAQ:OPNT) to announce ($0.31) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Two analysts have issued estimat
Experts are hopeful a coronavirus vaccine could be released early next year – but that doesn’t mean things will return to normal
Die US-amerikanische Zulassungsbehörde FDA (Food and Drug Administration) hat das digitale Einweg-Datenstreaming während der Patientenunterstützung du
"Whatever they can do to fix the data in the interim is great. Long-term, it needs to be improved in general," Dr. Bill Winkenwerder, former assistant Secretary of Defense for health affairs, said.
Becton Dickinson and Co. undefined said Wednesday that the U.S. government plans to buy 750,000 of the company's COVID-19 antigen diagnostic tests. The...
The company will have a chance to lay out its plans for weathering the pandemic and economic crisis through the second half of the year.
Equities research analysts forecast that Opiant Pharmaceuticals Inc (NASDAQ:OPNT) will post $6.47 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have
ChemWerth Inc., a leading full-service supplier of generic Active Pharmaceutical Ingredients (APIs), files its 500th Drug Master File with the FDA.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE